186 related articles for article (PubMed ID: 29706551)
21. Long-term recurrence of Dupuytren's disease treated with clostridium histolitycum collagenase. Surgical treatment and anatomopathological study.
Simón-Pérez C; Rodríguez-Mateos JI; Maestro IA; Alvarez-Quiñones M; Simon-Perez E; Martín-Ferrero MA
Arch Orthop Trauma Surg; 2024 May; 144(5):2085-2091. PubMed ID: 38653835
[TBL] [Abstract][Full Text] [Related]
22. Development of Collagenase Treatment for Dupuytren Disease.
Badalamente MA; Hurst LC
Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
[TBL] [Abstract][Full Text] [Related]
23. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
[TBL] [Abstract][Full Text] [Related]
24. Safety of Collagenase Clostridium histolyticum Injection Therapy for Peyronie Disease in Patients Continuing Antiplatelet or Anticoagulant Therapy.
Amighi A; Regets KV; Nork JJ; Mendhiratta N; Mills JN; Eleswarapu SV
J Sex Med; 2020 Feb; 17(2):353-356. PubMed ID: 31866126
[TBL] [Abstract][Full Text] [Related]
25. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium.
Verstreken F; Degreef I; Decramer A; Libberecht K; Vanhove W; Datco A; Vanhaecke J; Clermont D; Duerinckx J
Acta Orthop Belg; 2016 Aug; 82(2):397-404. PubMed ID: 27682305
[TBL] [Abstract][Full Text] [Related]
27. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
Dreise MM; Stenekes MW; Werker PM
J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
[TBL] [Abstract][Full Text] [Related]
28. Collagenase clostridium histolyticum for dupuytren contracture: patterns of use and effectiveness in clinical practice.
Peimer CA; Skodny P; Mackowiak JI
J Hand Surg Am; 2013 Dec; 38(12):2370-6. PubMed ID: 24140362
[TBL] [Abstract][Full Text] [Related]
29. Patient Satisfaction With Collagenase.
Bradley J; Warwick D
J Hand Surg Am; 2016 Jun; 41(6):689-97. PubMed ID: 27132016
[TBL] [Abstract][Full Text] [Related]
30. Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score.
VAN Nuffel M; Posthuma DE Boer J; Cootjans K; Borgers A; DE Smet L; Degreef I
Acta Orthop Belg; 2023 Jun; 89(2):233-240. PubMed ID: 37924539
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
[TBL] [Abstract][Full Text] [Related]
32. Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease.
Yafi FA; Anaissie J; Zurawin J; Sikka SC; Hellstrom WJ
J Sex Med; 2016 Apr; 13(4):684-9. PubMed ID: 27045265
[TBL] [Abstract][Full Text] [Related]
33. A
Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Skin Tears Following Collagenase Clostridium histolyticum to Treat Dupuytren Contractures.
Wei DH; Cantlon MB; Wakefield DB; Vitale MA
J Hand Surg Am; 2020 Oct; 45(10):989.e1-989.e10. PubMed ID: 32546304
[TBL] [Abstract][Full Text] [Related]
35. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
[TBL] [Abstract][Full Text] [Related]
36. Complications Following Collagenase Treatment for Dupuytren Contracture.
Wozniczka J; Canepa C; Mirarchi A; Solomon JS
Hand (N Y); 2017 Sep; 12(5):NP148-NP151. PubMed ID: 28635316
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
[TBL] [Abstract][Full Text] [Related]
38. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
Skov ST; Bisgaard T; Søndergaard P; Lange J
J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
[TBL] [Abstract][Full Text] [Related]
39. Skin graft loss resulting from collagenase clostridium histolyticum treatment of Dupuytren contracture: case report and review of the literature.
Swanson JW; Watt AJ; Vedder NB
J Hand Surg Am; 2013 Mar; 38(3):548-51. PubMed ID: 23391354
[TBL] [Abstract][Full Text] [Related]
40. Collagenase treatment of Dupuytren's contracture using a modified injection method: a prospective cohort study of skin tears in 164 hands, including short-term outcome.
Atroshi I; Nordenskjöld J; Lauritzson A; Ahlgren E; Waldau J; Waldén M
Acta Orthop; 2015 Jun; 86(3):310-5. PubMed ID: 25695745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
